VEERENDRA GUTTA
Allopathic & Osteopathic Physicians|Internal Medicine FORT WORTH, TX NPI 1457362162
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine TX ABBVIE INC. All categories
General Payments — all program years on this page
$1,053.91
- Category: General Payments
- Program years: PY2018–2024
- Record count: 60
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $163.07 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $163.07 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $55.35 | 3 |
| Celgene Corporation | $47.99 | 3 |
| Xeris Pharmaceuticals, Inc. | $23.98 | 1 |
| Gilead Sciences, Inc. | $19.19 | 1 |
| Janssen Pharmaceuticals, Inc | $16.56 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078200597 | Janssen Pharmaceuticals, Inc | $16.56 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101113472 | Celgene Corporation | $16.54 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101113476 | Celgene Corporation | $17.46 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101113478 | Celgene Corporation | $13.99 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103856483 | ABBVIE INC. | $18.73 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103856485 | ABBVIE INC. | $19.32 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103856487 | ABBVIE INC. | $17.30 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133764253 | Gilead Sciences, Inc. | $19.19 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144616693 | Xeris Pharmaceuticals, Inc. | $23.98 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.